• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

海洋微生物来源的多肽抗生素研究进展。

Recent Advances in Polypeptide Antibiotics Derived from Marine Microorganisms.

机构信息

Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education & Key Laboratory Pharmaceutical Engineering of Zhejiang Province & College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.

出版信息

Mar Drugs. 2023 Oct 22;21(10):547. doi: 10.3390/md21100547.

DOI:10.3390/md21100547
PMID:37888482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10608164/
Abstract

In the post-antibiotic era, the rapid development of antibiotic resistance and the shortage of available antibiotics are triggering a new health-care crisis. The discovery of novel and potent antibiotics to extend the antibiotic pipeline is urgent. Small-molecule antimicrobial peptides have a wide variety of antimicrobial spectra and multiple innovative antimicrobial mechanisms due to their rich structural diversity. Consequently, they have become a new research hotspot and are considered to be promising candidates for next-generation antibiotics. Therefore, we have compiled a collection of small-molecule antimicrobial peptides derived from marine microorganisms from the last fifteen years to show the recent advances in this field. We categorize these compounds into three classes-cyclic oligopeptides, cyclic depsipeptides, and cyclic lipopeptides-according to their structural features, and present their sources, structures, and antimicrobial spectrums, with a discussion of the structure activity relationships and mechanisms of action of some compounds.

摘要

在抗生素时代后,抗生素耐药性的迅速发展和可用抗生素的短缺引发了新的医疗保健危机。发现新型强效抗生素以延长抗生素库是当务之急。由于其丰富的结构多样性,小分子抗菌肽具有广泛的抗菌谱和多种创新的抗菌机制。因此,它们已成为新的研究热点,并被认为是下一代抗生素的有前途的候选物。因此,我们汇集了过去十五年中来自海洋微生物的小分子抗菌肽,以展示该领域的最新进展。我们根据结构特征将这些化合物分为三类-环寡肽,环去肽和环脂肽-并介绍它们的来源,结构和抗菌谱,并讨论一些化合物的结构-活性关系和作用机制。

相似文献

1
Recent Advances in Polypeptide Antibiotics Derived from Marine Microorganisms.海洋微生物来源的多肽抗生素研究进展。
Mar Drugs. 2023 Oct 22;21(10):547. doi: 10.3390/md21100547.
2
Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.海洋环肽:抗菌活性与合成策略。
Mar Drugs. 2022 Jun 15;20(6):397. doi: 10.3390/md20060397.
3
Cyanobacteria-derived peptide antibiotics discovered since 2000.2000 年以来发现的源自蓝藻的肽类抗生素。
Peptides. 2018 Sep;107:17-24. doi: 10.1016/j.peptides.2018.08.002. Epub 2018 Aug 2.
4
Structure-activity relationship study: short antimicrobial peptides.构效关系研究:短抗菌肽
J Pept Res. 1999 Jan;53(1):41-6. doi: 10.1111/j.1399-3011.1999.tb01615.x.
5
Bacterial Pathogens: Potential Source For Antimicrobial Peptides.细菌病原体:抗菌肽的潜在来源。
Curr Protein Pept Sci. 2023;24(7):551-566. doi: 10.2174/1389203724666230726100303.
6
Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?耐多药肠球菌感染:新化合物,新型抗菌疗法?
Trends Microbiol. 2017 Jun;25(6):467-479. doi: 10.1016/j.tim.2017.01.004. Epub 2017 Feb 13.
7
Medium-sized peptides from microbial sources with potential for antibacterial drug development.微生物来源的具有抗菌药物开发潜力的中等大小肽。
Nat Prod Rep. 2024 Aug 14;41(8):1235-1263. doi: 10.1039/d4np00002a.
8
Marine Invertebrate Antimicrobial Peptides and Their Potential as Novel Peptide Antibiotics.海洋无脊椎动物抗菌肽及其作为新型肽抗生素的潜力。
Mar Drugs. 2023 Sep 23;21(10):503. doi: 10.3390/md21100503.
9
Synthesis and Antimicrobial Activity of Short Analogues of the Marine Antimicrobial Peptide Turgencin A: Effects of SAR Optimizations, Cys-Cys Cyclization and Lipopeptide Modifications.海洋抗菌肽Turgencin A短类似物的合成及抗菌活性:构效关系优化、半胱氨酸-半胱氨酸环化和脂肽修饰的影响
Int J Mol Sci. 2022 Nov 10;23(22):13844. doi: 10.3390/ijms232213844.
10
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds.抗菌肽 (AMPs):一类有前景的抗菌化合物。
J Appl Microbiol. 2022 Mar;132(3):1573-1596. doi: 10.1111/jam.15314. Epub 2021 Oct 13.

引用本文的文献

1
Recent Advances in Marine-Derived Compounds as Potent Antibacterial and Antifungal Agents: A Comprehensive Review.海洋来源化合物作为强效抗菌和抗真菌剂的最新进展:全面综述。
Mar Drugs. 2024 Jul 29;22(8):348. doi: 10.3390/md22080348.

本文引用的文献

1
Fish Skin Mucus Extracts: An Underexplored Source of Antimicrobial Agents.鱼皮黏液提取物:抗菌剂的一个未充分开发的来源。
Mar Drugs. 2023 Jun 7;21(6):350. doi: 10.3390/md21060350.
2
Antimicrobial peptides for combating drug-resistant bacterial infections.用于对抗耐药细菌感染的抗菌肽。
Drug Resist Updat. 2023 May;68:100954. doi: 10.1016/j.drup.2023.100954. Epub 2023 Mar 1.
3
Identification and Characterization of Three New Antimicrobial Peptides from the Marine Mollusk (Gmelin, 1791).从海洋软体动物 (Gmelin,1791)中鉴定和表征三种新的抗菌肽。
Int J Mol Sci. 2023 Feb 14;24(4):3852. doi: 10.3390/ijms24043852.
4
Marine Organisms as a Prolific Source of Bioactive Depsipeptides.海洋生物作为生物活性环二肽的丰富来源。
Mar Drugs. 2023 Feb 11;21(2):120. doi: 10.3390/md21020120.
5
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.碳青霉烯类耐药铜绿假单胞菌和相关碳青霉烯酶(POP)的全球流行病学和临床结局:一项前瞻性队列研究。
Lancet Microbe. 2023 Mar;4(3):e159-e170. doi: 10.1016/S2666-5247(22)00329-9. Epub 2023 Feb 9.
6
Targeted isolation of antitubercular cycloheptapeptides and an unusual pyrroloindoline-containing new analog, asperpyrroindotide A, using LC-MS/MS-based molecular networking.使用基于液相色谱-串联质谱的分子网络技术,靶向分离抗结核环庚肽和一种含不寻常吡咯并吲哚啉的新类似物——曲霉吡咯吲哚肽A。
Mar Life Sci Technol. 2023;5(1):85-93. doi: 10.1007/s42995-022-00157-8. Epub 2023 Jan 20.
7
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019 年与 33 种细菌病原体相关的全球死亡率:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Dec 17;400(10369):2221-2248. doi: 10.1016/S0140-6736(22)02185-7. Epub 2022 Nov 21.
8
Total Synthesis and Biological Evaluation of Modified Ilamycin Derivatives.**标题**:修饰伊来霉素衍生物的全合成及生物评价
Mar Drugs. 2022 Oct 3;20(10):632. doi: 10.3390/md20100632.
9
Computational identification of a systemic antibiotic for gram-negative bacteria.计算鉴定革兰氏阴性菌的全身性抗生素。
Nat Microbiol. 2022 Oct;7(10):1661-1672. doi: 10.1038/s41564-022-01227-4. Epub 2022 Sep 26.
10
Evybactin is a DNA gyrase inhibitor that selectively kills Mycobacterium tuberculosis.依伐巴坦是一种 DNA 拓扑异构酶抑制剂,选择性杀死结核分枝杆菌。
Nat Chem Biol. 2022 Nov;18(11):1236-1244. doi: 10.1038/s41589-022-01102-7. Epub 2022 Aug 22.